Health Cor Management, L.P. Curis Inc Transaction History

Health Cor Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$7.45 - $16.27 $7.29 Million - $15.9 Million	-977,950 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$8.78 - $12.8 $12.3 Million - $17.9 Million	-1,396,420 Reduced 58.81%	977,950 $11.1 Million
Q4 2020 Feb 16, 2021	BUY	$1.08 - $8.2 $2.56 Million - $19.5 Million	2,374,370 New	2,374,370 $19.4 Million

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $409M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Health Cor Management, L.P. with notifications on news.